Table 4.
Multivariable model of demographic and treatment characteristics associated with poor health among survivors.
| Satisfaction | Resilience | Discomfort | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | OR* | 95% CI | P-Value | % | OR* | 95% CI | P-Value | % | OR* | 95% CI | P-Value | |
| Sex | ||||||||||||
| Male | 13.01 | 1.00 | 7.32 | 1.00 | 7.32 | 1.00 | ||||||
| Female | 25.00 | 2.46 | 1.28–4.75 | 0.01 | 13.59 | 2.41 | 1.01–5.78 | 0.05 | 16.85 | 2.71 | 1.22–6.06 | 0.01 |
| Current age group | ||||||||||||
| 15–17 years | 20.16 | 1.00 | 11.63 | 1.00 | 13.18 | 1.00 | ||||||
| 18–20 years | 20.22 | 0.86 | 0.45–1.65 | 0.66 | 10.67 | 0.56 | 0.24–1.30 | 0.18 | 12.92 | 0.97 | 0.46–2.05 | 0.93 |
| Age at diagnosis | ||||||||||||
| < 2 years | 18.18 | 1.00 | 9.09 | 1.00 | 12.63 | 1.00 | ||||||
| 2–4 years | 23.85 | 1.43 | 0.70–2.93 | 0.32 | 14.68 | 2.92 | 1.15–7.42 | 0.02 | 13.76 | 1.24 | 0.53–2.92 | 0.62 |
| Race/ethnicity | ||||||||||||
| White** | 20.45 | 1.00 | 10.41 | 1.00 | 12.64 | 1.00 | ||||||
| Non-white | 18.42 | 1.10 | 0.44–2.77 | 0.84 | 15.79 | 1.96 | 0.71–5.41 | 0.19 | 15.79 | 1.60 | 0.60–4.26 | 0.34 |
| Household income | ||||||||||||
| < 60,000/year | 21.28 | 1.00 | 13.30 | 1.00 | 12.23 | 1.00 | ||||||
| $60,000+/year | 19.27 | 0.77 | 0.41–1.44 | 0.41 | 6.42 | 0.40 | 0.16–0.98 | 0.04 | 14.68 | 1.23 | 0.61–2.51 | 0.56 |
| Diagnosis | ||||||||||||
| Leukemia | 21.05 | 1.00 | 14.74 | 1.00 | 13.68 | 1.00 | ||||||
| CNS Tumor | 40.00 | 2.98 | 1.25–7.07 | 0.01 | 10.00 | 1.01 | 0.28–3.62 | 0.98 | 17.50 | 1.50 | 0.52–4.34 | 0.46 |
| Neuroblastoma | 13.33 | 0.64 | 0.26–1.56 | 0.33 | 10.00 | 1.08 | 0.37–3.16 | 0.89 | 13.33 | 1.08 | 0.40–2.92 | 0.87 |
| Wilms' Tumor | 12.50 | 0.57 | 0.21–1.52 | 0.26 | 7.14 | 0.60 | 0.17–2.10 | 0.43 | 8.93 | 0.68 | 0.22–2.13 | 0.50 |
| Other | 26.92 | 1.43 | 0.51–4.04 | 0.49 | 11.54 | 0.95 | 0.23–3.86 | 0.94 | 11.54 | 0.85 | 0.22–3.36 | 0.82 |
| Risks | Disorders | Achievement | ||||||||||
| % | OR* | 95% CI | P-Value | % | OR* | 95% CI | P-Value | % | OR* | 95% CI | P-Value | |
| Sex | ||||||||||||
| Male | 13.01 | 1.00 | 17.89 | 1.00 | 11.48 | 1.00 | ||||||
| Female | 8.70 | 0.62 | 0.28–1.36 | 0.23 | 21.20 | 1.43 | 0.77–2.64 | 0.26 | 10.06 | 1.07 | 0.49–2.33 | 0.87 |
| Current age group | ||||||||||||
| 15–17 years | 12.40 | 1.00 | 22.48 | 1.00 | 10.32 | 1.00 | ||||||
| 18–20 years | 8.99 | 0.63 | 0.26–1.54 | 0.31 | 17.98 | 0.75 | 0.40–1.41 | 0.37 | 10.86 | 1.06 | 0.46–2.46 | 0.88 |
| Age at diagnosis | ||||||||||||
| < 2 years | 10.10 | 1.00 | 20.20 | 1.00 | 9.79 | 1.00 | ||||||
| 2–4 years | 11.01 | 0.84 | 0.31–2.27 | 0.73 | 19.27 | 1.29 | 0.62–2.69 | 0.50 | 12.15 | 1.09 | 0.44–2.71 | 0.86 |
| Race/ethnicity | ||||||||||||
| White | 9.29 | 1.00 | 18.22 | 1.00 | 9.51 | 1.00 | ||||||
| Non-White | 18.42 | 1.84 | 0.68–5.01 | 0.23 | 31.58 | 2.38 | 1.08–5.23 | 0.03 | 18.42 | 2.39 | 0.92–6.22 | 0.08 |
| Household income | ||||||||||||
| < 60,000/year | 10.11 | 1.00 | 20.74 | 1.00 | 12.50 | 1.00 | ||||||
| $60,000+/year | 10.09 | 0.95 | 0.42–2.14 | 0.90 | 19.27 | 0.83 | 0.45–1.54 | 0.56 | 7.48 | 0.53 | 0.22–1.25 | 0.15 |
| Diagnosis | ||||||||||||
| Leukemia | 12.63 | 1.00 | 17.89 | 1.00 | 13.83 | 1.00 | ||||||
| CNS Tumor | 2.50 | 0.15 | 0.02–1.27 | 0.08 | 32.50 | 2.63 | 1.06–6.48 | 0.04 | 15.38 | 1.31 | 0.43–4.01 | 0.64 |
| Neuroblastoma | 7.78 | 0.48 | 0.16–1.46 | 0.20 | 22.22 | 1.48 | 0.63–3.45 | 0.37 | 7.87 | 0.47 | 0.15–1.47 | 0.20 |
| Wilms' Tumor | 8.93 | 0.49 | 0.14–1.70 | 0.26 | 12.50 | 0.73 | 0.27–1.97 | 0.53 | 7.41 | 0.53 | 0.15–1.81 | 0.31 |
| Other | 26.92 | 2.19 | 0.71–6.78 | 0.17 | 15.38 | 0.93 | 0.28–3.16 | 0.91 | 8.00 | 0.61 | 0.12–2.98 | 0.54 |
*
Poor Health – defined for each domain based on 10th percentile cut-point score for sibling sample. See text.
Odds ratio represent ‘worse’ outcome
OR=Standardized risk ratios and 95% confidence intervals for multiple variable models